Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
38,512,859
-
Total 13F shares
-
31,494,188
-
Share change
-
+31,494,188
-
Total reported value
-
$1,036,457,376
-
Price per share
-
$32.91
-
Number of holders
-
69
-
Value change
-
+$1,036,457,376
-
Number of buys
-
69
Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q1 2021
As of 31 Mar 2021 Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) had 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 31,494,188 shares of stock of the company.
Largest 10 holders included Novo Holdings A/S, Vivo Capital, LLC, CITADEL ADVISORS LLC, FMR LLC, Sofinnova Investments, Inc., RA CAPITAL MANAGEMENT, L.P., Pivotal bioVenture Partners Investment Advisor LLC, Rock Springs Capital Management LP, BlackRock Inc., and Samsara BioCapital, LLC.
This table shows 69 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.